Skip to main content
. 2022 Nov 22;2(4):e12110. doi: 10.1002/jcv2.12110

TABLE 1.

Clinical and demographic characteristics of the sample

Sample characteristics
Low mood N % Typical mood N %
Biological sex Biological sex
Female 39 67.2 Female 41 70.7
Male 19 32.8 Male 17 29.3
Race Race
American Indian or Alaska Native 0 0.0 American Indian or Alaska Native 0 0.0
Asian 4 6.9 Asian 4 6.9
Black or African American 6 10.3 Black or African American 7 12.1
Native Hawaiian or other Pacific Islander 0 0.0 Native Hawaiian or other Pacific Islander 1 1.7
White 41 70.7 White 41 70.7
Other 1 1.7 Other 0 0.0
More than one race 6 10.3 More than one race 5 8.6
Ethnicity Ethnicity
Hispanic or Latino 5 8.6 Hispanic or Latino 4 6.9
Not Hispanic or Latino 53 91.4 Not Hispanic or Latino 54 93.1
Current diagnoses (DSM‐5) Current diagnoses (DSM‐5)
Major depressive episode 25 43.1 Major depressive episode 0 0.0
Generalized anxiety disorder 10 17.2 Generalized anxiety disorder 0 0.0
Social anxiety disorder 7 12.1 Social anxiety disorder 0 0.0
Panic disorder 2 3.5 Panic disorder 0 0.0
Specific phobia 1 1.7 Specific phobia 0 0.0
Attention‐deficit/ Attention‐deficit/
Hyperactivity disorder 4 6.9 Hyperactivity disorder 0 0.0
Oppositional defiant disorder 2 3.5 Oppositional defiant disorder 0 0.0
Medication Medication
SSRI 9 15.5 SSRI 0 0.0
M SD M SD
Age (in years) 15.9 1.8 Age (in years) 16.1 1.9
Family income (dollars) 126,000 68,000 Family income (dollars) 179,000 147,000
SHAPS score 34.4 5.8 SHAPS score 18.5 4.5
CES‐D score 33.4 9.9 CES‐D score 5.8 5.0

Note: There were no group differences in sex, race, ethnicity, or age (ps > .65). There were group differences in SHAPS (p < .001) and CESD severity (p < .001), as well as income (p = .025; 16 subjects did not report their income).

Abbreviations: DSM‐5, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; SHAPS, Snaith‐Hamilton Pleasure Scale; SSRI, selective serotonin reuptake inhibitor.